Open an account

Viveve Medical

VIVE · OTC

$0.0002+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About VIVE

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Company’s wholly owned subsidiaries include Viveve, Inc. and Viveve BV.

Employees
47
Headquarters
Englewood, Colorado
Listed
Mar 3, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
us.viveve.com

VIVE key statistics

Market cap
2.14K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
726
Volume
462
Open price
$0.0002
High today
$0.0002
Low today
$0.0002
52 Week high
$0.0009
52 Week low
$0.00

Viveve Medical (VIVE) at a glance

As of Oct 20, 2026, Viveve Medical (VIVE) shares are priced at $0.0002, giving the company a market cap of 2.14K and a price-to-earnings ratio of 0.00.

Volume so far is 462 shares, below the average of 726 shares a day.

Over the past year Viveve Medical has ranged from $0.00 to $0.0009, and now sits 22% of the way up that range.

Viveve Medical met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q3 FY22 it reported -$0.59 per share against an estimate of -$0.6732.

VIVE earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 10.7% on average.

  1. Q4 FY20: reported -$1.85 per share against an estimate of -$2.65
  2. Q1 FY21: reported -$0.80 per share against an estimate of -$0.5202
  3. Q2 FY21: reported -$0.62 per share against an estimate of -$0.663
  4. Q3 FY21: reported -$0.67 per share against an estimate of -$0.6273
  5. Q4 FY21: reported -$0.72 per share against an estimate of -$0.6069
  6. Q1 FY22: reported -$0.67 per share against an estimate of -$0.6885
  7. Q2 FY22: reported -$0.67 per share against an estimate of -$0.6834
  8. Q3 FY22: reported -$0.59 per share against an estimate of -$0.6732

Similar companies

Companies in the same industry as Viveve Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.